Skip to content

Pilot Study of Sensor-Informed Smartphone-based Mental Health Interventions for Mood in Early Psychosis

Development of Sensor-Informed Smartphone-Based Mental Health Intervention for Early Psychosis

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07503093
Enrollment
10
Registered
2026-03-31
Start date
2026-08-01
Completion date
2027-06-01
Last updated
2026-06-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Psychosis, Rumination

Keywords

Mirco-Randomized Study, Mobile Health, Psychosis, Digital Mental Health, Negative Mood, Digital Phenotyping, Passive Sensors

Brief summary

The aim of this trial is to evaluate the feasibility and preliminary efficacy of using passive smartphone sensors to detect moments of heightened negative mood and inform the timing of brief mental health interventions, such as mindfulness exercises and psychoeducation, in adults with early psychosis.

Detailed description

Negative mood symptoms are highly prevalent in early psychosis and strongly linked to long-term functional impairment and risk of relapse. Smartphone-based interventions offer a scalable and accessible solution for delivering personalized mental health support in daily life. The goal of this micro randomized trial (MRT) is to evaluate the feasibility of using passive smartphone sensor data and machine learning to identify optimal moments for delivering smartphone app-based brief mental health interventions such as mindfulness exercises and psychoeducation, specifically moments when individuals are both most in need of support and most receptive to it. The primary aim of this pilot study is to assess the feasibility and acceptability of the MRT study design, including recruitment and retention rates, EMA adherence, and participant feedback gathered through qualitative exit interviews to inform future design improvements. A secondary aim is to evaluate the feasibility of training an idiographic machine learning model using passive smartphone sensor data to detect moments of heightened negative affect. An exploratory aim is to estimate preliminary intervention effect sizes to inform a future fully powered clinical trial and to identify contextual factors associated with participant engagement.

Interventions

BEHAVIORALSmartphone-based Mindfulness Exercise

A brief approximately 1 minute video guided mindfulness based breathing exercise designed to anchor attention to the present moment and reduce negative affect in the moment by guiding participants through a structured breathing technique.

BEHAVIORALSmartphone-based Psychoeducation

A brief text or video based psychoeducation message delivered via the smartphone app. Content covers the nature of emotions and emotion regulation strategies, aimed at improving emotional awareness and coping skills in the moment.

BEHAVIORALNeutral Control Message

A brief text or video based message containing random facts delivered via the MetricWire smartphone app. This serves as an active control condition to allow comparison with the active intervention conditions.

Sponsors

Mclean Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This 10 week study has two phases. In Phase 1 (Weeks 1 to 4), participants complete four daily ecological momentary assessments of mood while passive smartphone sensor data including GPS, accelerometer, and phone usage patterns is collected continuously. Data from Phase 1 are used to train a personalized idiographic machine learning model to detect moments of heightened negative mood for each participant. After a one week break, Phase 2 (Weeks 6 to 9) uses a micro randomized trial (MRT) design, a within person experimental design in which each participant serves as their own control through repeated randomizations. Participants are randomly assigned four times per day to one of four conditions: mindfulness exercise, psychoeducation, neutral control. Brief EMA mood ratings are completed before and after each randomization event to measure proximal changes in negative mood.

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-50 years * History of DSM-5 psychotic disorder (e.g., schizophrenia, schizoaffective disorder, psychosis not otherwise specified) * Current elevated mood symptoms, defined as mild or greater depressive symptoms (Patient Health Questionnaire-8 score ≥5) or anxiety symptoms (Generalized Anxiety Disorder-7 score ≥5) * Own a personal iPhone or Android smartphone * Willing and able to provide informed consent * English-speaking

Exclusion criteria

* Active suicidal ideation with both intent and a specific plan. * Current substance use disorder requiring acute treatment * Diagnosis of neurodevelopmental disorder that would impair ability to use smartphone app or complete study procedures * Traumatic brain injury with significant cognitive impairment

Design outcomes

Primary

MeasureTime frameDescription
Retention Rate10 weeksProportion of enrolled participants who completed the full 10 week study protocol, including both Phase 1 and Phase 2.
EMA Completion Rate10 weeksProportion of ecological momentary assessment (EMA) prompts answered by participants out of the total number delivered during Phase 1 and Phase 2.
Participant Acceptability and SatisfactionWeek 10Participant acceptability and satisfaction with the study app and intervention content, assessed through a structured qualitative exit interview and feedback questionnaire at the end of the study.

Secondary

MeasureTime frameDescription
Proximal Change in Negative Affect4 weeksChange in self reported negative affect from pre to post intervention phone-based ecological momentary assessment at each randomization event during the micro-randomized trial. Negative affect is assessed using a visual analog scale (0 to 100) measuring sadness, anxiousness, irritability, and rumination. Active intervention conditions (mindfulness and psychoeducation) are compared to neutral control conditions to generate preliminary effect size estimates.
Patient Health Questionnaire-8 (PHQ-8)4 weeksAll participants complete the Patient Health Questionnaire-8 (PHQ-8), an 8-item self-report measure of depressive symptom severity, at the start and at the end of the study. Each item is rated on a scale of 0 (not at all) to 3 (nearly every day), with total scores ranging from 0 to 24. Higher scores indicate greater depressive symptom burden.
Generalized Anxiety Disorder-7 (GAD-7)4 weeksAll participants complete the Generalized Anxiety Disorder-7 (GAD-7), a 7-item self-report measure of anxiety symptom severity, at the start and at the end of the study. Each item is rated on a scale of 0 (not at all) to 3 (nearly every day), with total scores ranging from 0 to 21. Higher scores indicate greater anxiety symptom burdens.

Countries

United States

Contacts

CONTACTYoonho Chung, PhD
ychung3@mgb.org617-855-2854
CONTACTJustin T Baker, MD, PhD
jtbaker@mgb.org617-855-3913

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 26, 2026